We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Online Visipaque Pages Draw Untitled Letter
Online Visipaque Pages Draw Untitled Letter
January 29, 2010
GE Healthcare omitted important risk information and presented unsubstantiated comparative claims online for its contrast agent Visipaque, according to an FDA untitled letter.